Local research. Human connections. WCR Miami Lakes (786) 483-7856
Back to study searchNCT06144164
RecruitingNCT06144164ClinicalTrials.gov record

A Study of a Comprehensive Prevention Program to Reduce Lymphedema After Axillary Lymph Node Dissection in People With Breast Cancer

Lymphedema · Lymphedema Arm · Lymphedema of Upper Arm · Breast Cancer · Breast Carcinoma · Female Breast Cancer

THE QUICK READ

What this study involves

The registry says this study is recruiting. Individual locations may have different availability.

Study type
Interventional
Phase
Phase 3
Age range
18 years - 75 years
Sex eligible
Female
Healthy volunteers
Not accepted
Participants
285 Estimated

These are starting points, not an eligibility decision. The research team must review the full requirements.

About the research

The purpose of this study to test whether a comprehensive program may help the lymph fluid to drain out of the arm and prevent lymphedema in participants with breast cancer.

Who may be able to participate?

The list below is the sponsor’s full registry wording. It can include conditions, prior treatment, test results and other requirements. A match in search does not mean you qualify.

Inclusion Criteria:

  • Female sex
  • Diagnosis of breast cancer
  • Ages 18 to 75 years
  • Consented for unilateral ALND or for unilateral SLNB with possible ALND

Exclusion Criteria:

  • Male sex
  • Does not speak English
  • Does not fit into study garment
  • Axillary recurrence
  • History of ALND
  • Requirement of bilateral ALND for the treatment of breast cancer
  • Treatment with SLNB only
  • Known anaphylactic allergy to ICG dye used in ILR
  • Impaired decision-making capacity
Understand screening

Treatment, groups and participation

The registry may describe treatments and study duration without a complete visit calendar. Ask the study team for the exact schedule, procedures, risks, costs and alternatives. Keep your usual care plan unless your treating clinician tells you otherwise.

Assignment
Not applicable
Masking
No masking
Participants with Breast Cancer

Participants will have a diagnosis of breast cancer and may undergo axillary lymph node dissection.

Procedure: Immediate Lymphatic Reconstruction · Diagnostic Test: Volumetric arm measurements · Other: Lymphatic massage · Other: Range of motion exercises · Other: Compression garment use

Immediate Lymphatic Reconstruction PROCEDURE

Immediate Lymphatic Reconstruction will happen at the time of Axillary Lymph Node Dissection

Volumetric arm measurements DIAGNOSTIC_TEST

Volumetric arm measurements will occur at each in-person postoperative visit time points.

Lymphatic massage OTHER

Participants will begin self-directed lymphatic massage 24 to 48 h after surgery and will continue to do lymphatic massage 3 times a week for 3 months after surgery or until 3 months after any adjuvant treatments (chemotherapy, radiation, etc.) are completed

Range of motion exercises OTHER

Participants will begin self-directed lymphatic massage 24 to 48 h after surgery and will continue to do lymphatic massage 3 times a week for 3 months after surgery or until 3 months after any adjuvant treatments (chemotherapy, radiation, etc.) are completed

Compression garment use OTHER

Participants will use compression garments 24 to 48 h after surgery and will continue daily use for at least 8 h a day for 3 months or until 3 months after any adjuvant treatments are completed

Prepare your questions

What researchers are measuring

Outcome measures describe what is being studied. They are not proof that a treatment works.

Primary measures

The difference between the baseline and postoperative arm volume measurement

Time frame: Up to 24 months

The primary objective is to determine the efficacy of a prevention program in decreasing the development of lymphedema in participants treated for breast cancer with Axillary Lymph Node Dissection/ALND by use of arm volume measurements. A ≥ 10% increase in RVC (arm volume difference between the affected and unaffected arms) between baseline and postoperative measures occurring at 12 months or later will indicate the development of lymphedema

No results are flagged as posted.

Review the complete result tables and limitations in the official record.

Open official results ↗

Research locations (7)

The overall study status and a local site’s status can differ. Confirm that location’s availability before traveling.

7 locations

Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities)Basking Ridge, New Jersey, United StatesRecruiting
Michelle Coriddi, MDCONTACT646-608-8042
View location on map ↗
Memorial Sloan Kettering Monmouth (Limited Protocol Activities)Middletown, New Jersey, United StatesRecruiting
Michelle Coriddi, MDCONTACT646-608-8042
View location on map ↗
Memorial Sloan Kettering Bergen (Limited Protocol Activities)Montvale, New Jersey, United StatesRecruiting
Michelle Coriddi, MDCONTACT646-608-8042
View location on map ↗
Memorial Sloan Kettering Commack (Limited Protocol Activities)Commack, New York, United StatesRecruiting
Michelle Coriddi, MDCONTACT646-608-8042
View location on map ↗
Memorial Sloan Kettering Westchester (Limited Protocol Activities)Harrison, New York, United StatesRecruiting
Michelle Coriddi, MDCONTACT646-608-8042
View location on map ↗
Memorial Sloan Kettering Cancer Center (All Protocol Activities)New York, New York, United StatesRecruiting
Michelle Coriddi, MDCONTACT646-608-8042
View location on map ↗
Memorial Sloan Kettering Nassau (Limited Protocol Activities)Uniondale, New York, United StatesRecruiting
Michelle Coriddi, MDCONTACT646-608-8042
View location on map ↗

Study team and timeline

Lead sponsor
Memorial Sloan Kettering Cancer Center
Study start
Nov 16, 2023 Actual
Primary completion
Mar 16, 2030 Estimated
Study completion
Mar 16, 2030 Estimated
First posted
Nov 22, 2023 Actual
Last updated
Nov 10, 2026 Actual

Official study contacts

Michelle Coriddi, MDCONTACTcoriddim@mskcc.org646-608-8042
Babak Mahrara, MDCONTACTmehrarab@MSKCC.ORG646-608-8085
Official study title

A Prospective Cohort Study of Patients Undergoing ALND for Treatment of Breast Cancer: The Efficacy of a Comprehensive Prevention Program in Decreasing the Incidence of Lymphedema and Improving Quality of Life

A HUMAN NEXT STEP

Ask Wellness Clinical Research

Your message goes to WCR, including when this study is run by another organization. WCR may offer general guidance but may not operate this trial, have access to its team or be able to enroll you.

Please do not include medical records, diagnoses, medications, insurance numbers or other sensitive details. This form is for general questions, not urgent care.

Sending a question does not enroll you in a trial.

Source: ClinicalTrials.gov API v2. Information is submitted by sponsors and investigators. NLM does not approve the safety or science of all listed studies. Registry disclaimer.

Retrieved: Nov 11, 2026 · Last registry update: Nov 10, 2026